Back to mobile site

More on EVAX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-200.0% Growth)
- Ratings (10.0 Score)

Upcoming Events

- Earnings (11/19/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Evaxion Biotech (NQ:EVAX)
Delayed: 3.22 +0.19 (6.27%)
Prev. Close $3.03  
Open$3.10 
52 Wk High$ 
52 Wk Low$ 
Day High$3.25 
Day Low$3.05 
P/E N/A  
EPS$ 
Volume53,340 

Friends, Peers and Foes (?): ABL, ACIC, BAER, BODI, CIA (more...)

Sep 14, 2026 08:05 AM Form 6-K Evaxion A/S For: Sep 14
Sep 14, 2026 08:03 AM Evaxion expands AI platform into autoimmune disease research
Sep 14, 2026 08:00 AM Evaxion applies its AI-Immunology™ platform in autoimmune diseases
Aug 20, 2026 07:35 AM Form 6-K Evaxion A/S For: Aug 20
Aug 20, 2026 07:31 AM Evaxion posts $3.7M Q2 loss, advances cancer vaccine pipeline
Aug 20, 2026 07:30 AM Form 6-K Evaxion A/S For: Jun 30
Aug 20, 2026 07:30 AM Evaxion announces business update and second quarter 2026 financial results
Aug 17, 2026 08:05 AM Form 6-K Evaxion A/S For: Aug 17
Aug 17, 2026 08:02 AM Evaxion adds brain cancer vaccine program, drops EVX-03
Aug 17, 2026 08:00 AM Evaxion expands and refocuses R&D pipeline with EVX-05, an AI-designed off-the-shelf brain cancer vaccine program
View All Articles

Entities mentioned with EVAX

View All Entities